My HPRA: Register

The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Migraleve Pink Film-coated Tablets Paracetamol 500mg Codeine Phosphate 8mg Buclizine Hydrochloride 6.25mg



JNTL Consumer Health I (Ireland) LimitedPA23490/014/001

Main Information

Trade NameMigraleve Pink Film-coated Tablets Paracetamol 500mg Codeine Phosphate 8mg Buclizine Hydrochloride 6.25mg
Active SubstancesParacetamol
Codeine phosphate hemihydrate
BUCLIZINE HYDROCHLORIDE
Dosage FormFilm-coated tablet
Licence HolderJNTL Consumer Health I (Ireland) Limited
Licence NumberPA23490/014/001

Group Information

ATC CodeN02BE Anilides
N02BE51 paracetamol, combinations excl. psycholeptics

Status

License statusAuthorised
Licence Issued01/04/1978
Legal statusProduct not subject to medical prescription
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceProduct not subject to medical prescription for pack sizes of up to 24 tablets. Product subject to prescription which may not be renewed for pack sizes of over 24 tablets. Promotion to healthcare professionals only and as a prescription-only medicine for pack sizes of over 24 tablets.
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back
Follow medicine

Print